Literature DB >> 9721161

Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

T Watanabe1, M Tada, H Nagai, S Sasaki, M Nakao.   

Abstract

BACKGROUND & AIMS: Although epidemiological studies have indicated that Helicobacter pylori infection plays a crucial role in gastric carcinogenesis in humans, there is no direct proof that H. pylori is actually associated with gastric carcinogenesis. The purpose of this study was to elucidate the relationship between H. pylori infection and gastric carcinogenesis using an animal model of long-term H. pylori infection.
METHODS: Mongolian gerbils were orally inoculated with H. pylori, and the sequential morphological changes in the stomach were examined for up to 62 weeks.
RESULTS: H. pylori was constantly detected in all infected animals throughout the study. At the 26th week, severe active chronic gastritis, ulcers, and intestinal metaplasia could be observed in infected animals. By the end of the study, adenocarcinoma had developed in the pyloric region of 37% of the infected animals. All tumors consisted of well-differentiated intestinal-type epithelium, and their development seemed to be closely related to intestinal metaplasia.
CONCLUSIONS: We have successfully demonstrated that long-term infection with H. pylori induces adenocarcinoma in Mongolian gerbils. The observations are thus highly suggestive of the involvement of H. pylori infection in gastric carcinogenesis in humans.

Entities:  

Mesh:

Year:  1998        PMID: 9721161     DOI: 10.1016/s0016-5085(98)70143-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  264 in total

1.  Molecular mechanisms of H. pylori associated gastric carcinogenesis.

Authors:  Zun-Wu Zhang; Michael JG Farthing
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  The importance of interleukin 1beta in Helicobacter pylori associated disease.

Authors:  E M El-Omar
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Comparative analysis of colonization of Helicobacter pylori and glycolipids receptor density in Mongolian gerbils and mice.

Authors:  H Osawa; K Sugano; M Iwamori; M Kawakami; M Tada; M Nakao
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

4.  Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.

Authors:  M Takashima; T Furuta; H Hanai; H Sugimura; E Kaneko
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

5.  Somatostatin methylation as a biomarker for gastric cancer: ready for "prime time" or for further validation?

Authors:  Ajay Goel
Journal:  Dig Dis Sci       Date:  2011-01       Impact factor: 3.199

6.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

7.  Serum glycan signatures of gastric cancer.

Authors:  Sureyya Ozcan; Donald A Barkauskas; L Renee Ruhaak; Javier Torres; Cara L Cooke; Hyun Joo An; Serenus Hua; Cynthia C Williams; Lauren M Dimapasoc; Jae Han Kim; Margarita Camorlinga-Ponce; David Rocke; Carlito B Lebrilla; Jay V Solnick
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

8.  A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China.

Authors:  Ran Tao; Ping-Chu Fang; Hai-Yan Liu; Yun-Shui Jiang; Jing Chen
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.

Authors:  Fen Wang; Li-Dan Luo; Jian-Hua Pan; Li-Hua Huang; Hong-Wei Lv; Qin Guo; Can-Xia Xu; Shou-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Childhood Helicobacter pylori infection in a murine model: maternal transmission and eradication by systemic immunization using bacterial antigen-aluminium hydroxide.

Authors:  T Minoura; S Kato; S Otsu; T Fujioka; K Iinuma; A Nishizono
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.